Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P130008/S147

Model 3150 IPG

Inspire Medical Systems · Decision date Oct 22, 2026

MEDTECHLEDGER EXPLANATIONP130008/S147

What did the FDA decide?

The FDA recorded decision OK30 on 2026-10-22 for PMA supplement P130008/S147, submitted by Inspire Medical Systems as a 30-Day Notice under the process change category covering manufacturer, sterilizer, packager or supplier. The supplement concerns the Model 3150 Implantable Pulse Generator, a hypoglossal nerve stimulator for implanted apnea therapy (product code MNQ, listed under anesthesiology).

The recorded scope is expansion of the existing Model 3028 IPG final device manufacturer's site so that it can also produce the Model 3150 IPG. This is a manufacturing-site change within the existing approval, not a new approval of the device or its labeling. The source record includes no documents, so the site identity, inspection status and any conditions attached to OK30 remain unknown, as does whether the Model 3150 differs from the Model 3028 beyond production location.

FDA approval order statement

approval for the expansion of Inspire Medical's existing Model 3028 Implantable Pulse Generator (IPG) final device manufacturer's site to produce the Model 3150 IPG
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Anesthesiology
Decision date
Oct 22, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P130008/S147
Regulatory pathway
PMA supplement
Product code
MNQ
Decision code
OK30
Decision date
Oct 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, hypoglossal nerve, implanted, apnea.

Product code
MNQ
FDA device class
3

For the original device and its historical approval scope, see PMA P130008. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P130008 · Original PMA

    INSPIRE II UPPER AIRWAY STIMULATOR

  2. P130008/S147 received

    Application receipt date recorded by FDA.

  3. P130008/S147 · FDA decision

    30-Day Notice

  4. P130008/S144 · Related supplement

    INSPIRE II UPPER AIRWAY STIMULATOR

  5. P130008/S148 · Related supplement

    Model 4063 Dedicated Tray Sealer

Timeline entries are records held by MedtechLedger for P130008. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P130008

Product / regulatory recordCompanyPathwayDecision dateSource
Inspire Medical SystemsPMA approvalApr 30, 2014FDA
Model 3150 IPGP130008/S146
Inspire Medical SystemsPMA supplementOct 13, 2026FDA
Inspire Medical SystemsPMA supplementOct 26, 2026FDA
Inspire Medical SystemsPMA supplementNov 5, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Inspire Medical Systems

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9700 63rd Ave. N., Suite 200, Maple Grove, MN, 55369

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records